Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2007-02-08Clinical Trial Update: Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis [Phase 2, Phase 3]
Open-label phase 2/3 trial evaluating rituximab (MabThera) in ankylosing spondylitis; status is not specified in the document.
-
CLINICAL_TRIALS research · 2007-01-04Clinical Trial Update: Blocking Tumor Necrosis Factor in Ankylosing Spondylitis [Phase 2]
A Phase 2 trial investigating blockade of tumor necrosis factor in ankylosing spondylitis has completed. This update notes completion but do…